These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
476 related items for PubMed ID: 27281700
1. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome. Kamiyoshi N, Nozu K, Fu XJ, Morisada N, Nozu Y, Ye MJ, Imafuku A, Miura K, Yamamura T, Minamikawa S, Shono A, Ninchoji T, Morioka I, Nakanishi K, Yoshikawa N, Kaito H, Iijima K. Clin J Am Soc Nephrol; 2016 Aug 08; 11(8):1441-1449. PubMed ID: 27281700 [Abstract] [Full Text] [Related]
2. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically. Imafuku A, Nozu K, Sawa N, Hasegawa E, Hiramatsu R, Kawada M, Hoshino J, Tanaka K, Ishii Y, Takaichi K, Fujii T, Ohashi K, Iijima K, Ubara Y. Nephrology (Carlton); 2018 Oct 08; 23(10):940-947. PubMed ID: 28704582 [Abstract] [Full Text] [Related]
3. Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene. Pescucci C, Mari F, Longo I, Vogiatzi P, Caselli R, Scala E, Abaterusso C, Gusmano R, Seri M, Miglietti N, Bresin E, Renieri A. Kidney Int; 2004 May 08; 65(5):1598-603. PubMed ID: 15086897 [Abstract] [Full Text] [Related]
4. COL4A3 mutation is an independent risk factor for poor prognosis in children with Alport syndrome. Ozdemir G, Gulhan B, Atayar E, Saygılı S, Soylemezoglu O, Ozcakar ZB, Eroglu FK, Candan C, Demir BK, Soylu A, Yüksel S, Alpay H, Agbas A, Duzova A, Hayran M, Ozaltin F, Topaloglu R. Pediatr Nephrol; 2020 Oct 08; 35(10):1941-1952. PubMed ID: 32394188 [Abstract] [Full Text] [Related]
5. Heterozygous COL4A3/COL4A4 mutations: the hidden part of the iceberg? Mastrangelo A, Madeira C, Castorina P, Giani M, Montini G. Nephrol Dial Transplant; 2022 Nov 23; 37(12):2398-2407. PubMed ID: 35090027 [Abstract] [Full Text] [Related]
8. Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort Study. Furlano M, Martínez V, Pybus M, Arce Y, Crespí J, Venegas MDP, Bullich G, Domingo A, Ayasreh N, Benito S, Lorente L, Ruíz P, Gonzalez VL, Arlandis R, Cabello E, Torres F, Guirado L, Ars E, Torra R. Am J Kidney Dis; 2021 Oct 23; 78(4):560-570.e1. PubMed ID: 33838161 [Abstract] [Full Text] [Related]
10. COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome. Storey H, Savige J, Sivakumar V, Abbs S, Flinter FA. J Am Soc Nephrol; 2013 Dec 23; 24(12):1945-54. PubMed ID: 24052634 [Abstract] [Full Text] [Related]
11. Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families. Longo I, Scala E, Mari F, Caselli R, Pescucci C, Mencarelli MA, Speciale C, Giani M, Bresin E, Caringella DA, Borochowitz ZU, Siriwardena K, Winship I, Renieri A, Meloni I. Nephrol Dial Transplant; 2006 Mar 23; 21(3):665-71. PubMed ID: 16338941 [Abstract] [Full Text] [Related]
12. Phenotype variability in a large Spanish family with Alport syndrome associated with novel mutations in COL4A3 gene. Cervera-Acedo C, Coloma A, Huarte-Loza E, Sierra-Carpio M, Domínguez-Garrido E. BMC Nephrol; 2017 Oct 31; 18(1):325. PubMed ID: 29089023 [Abstract] [Full Text] [Related]
19. Identification of a new mutation in the alpha4(IV) collagen gene in a family with autosomal dominant Alport syndrome and hypercholesterolaemia. Ciccarese M, Casu D, Ki Wong F, Faedda R, Arvidsson S, Tonolo G, Luthman H, Satta A. Nephrol Dial Transplant; 2001 Oct 31; 16(10):2008-12. PubMed ID: 11572889 [Abstract] [Full Text] [Related]